Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$67.00K$67.00Kderivedno prior Q4 2023 on file Net Income-$4.42M-$4.42MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$67,000— Operating Incomederived-$4,767,000N/M Operating Cash Flowderived-$4,693,000N/M Margins · derivedGross margin100.0%
Operating margin-7114.9%
Net margin-6595.5%
ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d after period end